These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34973393)

  • 1. Contrast Ultrasound Assessment of Skeletal Muscle Recruitable Perfusion after Permanent Left Ventricular Assist Device Implantation: Implications for Functional Recovery.
    Soman D; Hodovan J; Macon CJ; Davidson BP; Belcik JT; Mudd JO; Park BS; Lindner JR
    J Am Soc Echocardiogr; 2022 May; 35(5):495-502. PubMed ID: 34973393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-Enhanced Ultrasound of Muscle Perfusion May Indicate Patient Response to Left Ventricular Assist Device Therapy.
    Delaney LJ; Fitzgerald K; Stanczak M; Machado P; Entwistle JWC; Forsberg F; Reeves GR
    J Ultrasound Med; 2021 Dec; 40(12):2675-2683. PubMed ID: 33665892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiopulmonary Performance Among Heart Failure Patients Before and After Left Ventricular Assist Device Implantation.
    Buchanan C; Buchanan C; Riordan M; Byrd J; Schulte M; Kohrt WM; Ambardekar AV; Allen LA; Wolfel G; Lawley J; Levine BD; Cornwell WK
    JACC Heart Fail; 2024 Jan; 12(1):117-129. PubMed ID: 37632493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility.
    Witman MA; Garten RS; Gifford JR; Groot HJ; Trinity JD; Stehlik J; Nativi JN; Selzman CH; Drakos SG; Richardson RS
    JACC Heart Fail; 2015 Sep; 3(9):703-11. PubMed ID: 26277768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise versus vasodilator stress limb perfusion imaging for the assessment of peripheral artery disease.
    Davidson BP; Belcik JT; Landry G; Linden J; Lindner JR
    Echocardiography; 2017 Aug; 34(8):1187-1194. PubMed ID: 28664576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Continuous-Flow Left Ventricular Assist Device Therapy on Peripheral Vascular Function.
    Kaya E; Kocabas U; Simsek E; Nalbantgil S; Kahraman U; Engin C; Yagdi T; Ozbaran M; Akilli A
    ASAIO J; 2022 Feb; 68(2):214-219. PubMed ID: 35089263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy.
    Tansley P; Yacoub M; Rimoldi O; Birks E; Hardy J; Hipkin M; Bowles C; Kindler H; Dutka D; Camici PG
    J Heart Lung Transplant; 2004 Nov; 23(11):1283-9. PubMed ID: 15539127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: Role of microparticles.
    Sansone R; Stanske B; Keymel S; Schuler D; Horn P; Saeed D; Boeken U; Westenfeld R; Lichtenberg A; Kelm M; Heiss C
    J Heart Lung Transplant; 2015 Jul; 34(7):921-32. PubMed ID: 25980571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.
    Starling RC; Estep JD; Horstmanshof DA; Milano CA; Stehlik J; Shah KB; Bruckner BA; Lee S; Long JW; Selzman CH; Kasirajan V; Haas DC; Boyle AJ; Chuang J; Farrar DJ; Rogers JG;
    JACC Heart Fail; 2017 Jul; 5(7):518-527. PubMed ID: 28396040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic findings in stable outpatients with properly functioning HeartMate II left ventricular assist devices.
    Topilsky Y; Oh JK; Atchison FW; Shah DK; Bichara VM; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
    J Am Soc Echocardiogr; 2011 Feb; 24(2):157-69. PubMed ID: 21281909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairments in Blood Pressure Regulation and Cardiac Baroreceptor Sensitivity Among Patients With Heart Failure Supported With Continuous-Flow Left Ventricular Assist Devices.
    Sailer C; Edelmann H; Buchanan C; Giro P; Babcock M; Swanson C; Spotts M; Schulte M; Pratt-Cordova A; Coe G; Beindorff M; Page RL; Ambardekar AV; Pal JD; Kohrt W; Wolfel E; Lawley JS; Tarumi T; Cornwell WK
    Circ Heart Fail; 2021 Jan; 14(1):e007448. PubMed ID: 33464953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
    Maybaum S; Mancini D; Xydas S; Starling RC; Aaronson K; Pagani FD; Miller LW; Margulies K; McRee S; Frazier OH; Torre-Amione G;
    Circulation; 2007 May; 115(19):2497-505. PubMed ID: 17485581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial.
    Jaski BE; Lingle RJ; Kim J; Branch KR; Goldsmith R; Johnson MR; Lahpor JR; Icenogle TB; Piña I; Adamson R; Favrot LK; Dembitsky WP
    J Heart Lung Transplant; 1999 Nov; 18(11):1031-40. PubMed ID: 10598726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronotropic incompetence and abnormal heart rate recovery early after left ventricular assist device implantation.
    Dimopoulos S; Diakos N; Tseliou E; Tasoulis A; Mpouchla A; Manetos C; Katsaros L; Drakos S; Terrovitis J; Nanas S
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1607-14. PubMed ID: 21950763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac recovery following left ventricular assist device therapy: experience of complete device explantation including ventricular patch plasty.
    Gyoten T; Rojas SV; Fox H; Hata M; Deutsch MA; Schramm R; Gummert JF; Morshuis M
    Eur J Cardiothorac Surg; 2021 Apr; 59(4):855-862. PubMed ID: 33367693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy.
    Compostella L; Russo N; Setzu T; Compostella C; Bellotto F
    Artif Organs; 2014 May; 38(5):366-73. PubMed ID: 24117945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of reduced skeletal muscle perfusion reserve to exercise intolerance in heart failure with preserved ejection fraction.
    Serafin A; Jasic-Szpak E; Marwick TH; Przewlocka-Kosmala M; Ponikowski P; Kosmala W
    Int J Cardiol; 2024 Jan; 395():131553. PubMed ID: 37871664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise capacity recovers slowly but fully in patients with a left ventricular assist device.
    Nishimura M; Radovancevic B; Odegaard P; Myers T; Springer W; Frazier OH
    ASAIO J; 1996; 42(5):M568-70. PubMed ID: 8944943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.